These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25458274)

  • 1. Polysaccharide purification from Haemophilus influenzae type b through tangential microfiltration.
    Albani SM; da Silva MR; Fratelli F; Junior CP; Iourtov D; Cintra Fde O; Takagi M; Cabrera-Crespo J
    Carbohydr Polym; 2015 Feb; 116():67-73. PubMed ID: 25458274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of capsular polysaccharide produced by Haemophilus influenzae type b through a simple, efficient and suitable method for scale-up.
    Takagi M; Lima RB; Albani SM; Zangirolami TC; Tanizaki MM; Cabrera-Crespo J
    J Ind Microbiol Biotechnol; 2008 Nov; 35(11):1217-22. PubMed ID: 18712545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in the purification process of the capsular polysaccharide from Haemophilus influenzae type b by using tangential ultrafiltration and diafiltration.
    Albani SM; da Silva MR; Takagi M; Cabrera-Crespo J
    Appl Biochem Biotechnol; 2012 Aug; 167(7):2068-75. PubMed ID: 22665219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the chemical stability of the capsular polysaccharide produced by Haemophilus influenzae type b.
    Cintra Fde O; Takagi M
    Carbohydr Polym; 2015 Feb; 116():167-72. PubMed ID: 25458286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of ribose and phosphorus contents in Haemophilus influenzae type b capsular polysaccharide by a quantitative NMR method using a single internal standard.
    Qin CJ; Hu J; Tong W; Zhang TT; Tian GZ; Zou XP; Liu JK; Yin J
    Chin J Nat Med; 2022 Aug; 20(8):633-640. PubMed ID: 36031235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a high-resolution magic-angle spinning nuclear magnetic resonance identity assay of the capsular polysaccharide from Haemophilus influenzae type b present in cetavlon precipitate.
    Wieruszeski JM; Talaga P; Lippens G
    Anal Biochem; 2005 Mar; 338(1):20-5. PubMed ID: 15707931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of polysaccharide production of haemophilus influenzae Type b and its relationship to bacterial cell growth.
    Takagi M; Cabrera-Crespo J; Baruque-Ramos J; Zangirolami TC; Raw I; Tanizaki MM
    Appl Biochem Biotechnol; 2003 Aug; 110(2):91-100. PubMed ID: 14515024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB.
    Xu Q; Klees J; Teyral J; Capen R; Huang M; Sturgess AW; Hennessey JP; Washabaugh M; Sitrin R; Abeygunawardana C
    Anal Biochem; 2005 Feb; 337(2):235-45. PubMed ID: 15691503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
    Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
    Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental design and metabolic flux analysis tools to optimize industrially relevant Haemophilus influenzae type b growth medium.
    da Silva MR; Andreia Freixo Portela C; Maria Ferreira Albani S; Rizzo de Paiva P; Massako Tanizaki M; Zangirolami TC
    Biotechnol Prog; 2017 Nov; 33(6):1508-1519. PubMed ID: 28840658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples.
    van der Put RM; de Haan A; van den IJssel JG; Hamidi A; Beurret M
    Vaccine; 2015 Nov; 33(48):6908-13. PubMed ID: 25045809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific characteristics of composition of synthetic nutrient media for cultivation of Hemophilus influenzae type b from the standpoint of bacterial metabolism].
    Orlova OE; Iastrebova NE; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (3):111-7. PubMed ID: 11550547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths.
    Rana R; Dalal J; Singh D; Kumar N; Hanif S; Joshi N; Chhikara MK
    Vaccine; 2015 May; 33(23):2646-54. PubMed ID: 25907408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide.
    de Haan A; van der Put RM; Beurret M
    Biomed Chromatogr; 2013 Sep; 27(9):1137-42. PubMed ID: 23681893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of capsular polysaccharide from Streptococcus pneumoniae serotype 23F by a procedure suitable for scale-up.
    Gonçalves VM; Takagi M; Lima RB; Massaldi H; Giordano RC; Tanizaki MM
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):283-7. PubMed ID: 12515577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
    Townsend K; Ladhani SN; Findlow H; Borrow R
    Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b.
    Anderson P; Smith DH
    Infect Immun; 1977 Feb; 15(2):472-7. PubMed ID: 300361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
    Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ
    Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b.
    Lemercinier X; Jones C
    Biologicals; 2000 Sep; 28(3):175-83. PubMed ID: 10964444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.